CONSUN PHARMACEUTICAL GROUP LIMITED Consun Pharmaceutical Group Limited Stock Deutsche Boerse AG
Equities
C1P
KYG2524A1031
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9 EUR | +27.66% |
|
+69.81% | +69.81% |
| 06-21 | Consun Pharmaceutical Group Limited Announces Board and Committee Changes | CI |
| 05-31 | Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
| Sales 2024 * | 2.93B 403M 377M 552M | Sales 2025 * | 3.33B 459M 428M 628M | Capitalization | 4.27B 588M 549M 805M |
|---|---|---|---|---|---|
| Net income 2024 * | 897M 123M 115M 169M | Net income 2025 * | 1.04B 144M 134M 197M | EV / Sales 2024 * | 0.54 x |
| Net cash position 2024 * | 2.69B 370M 346M 507M | Net cash position 2025 * | 3.22B 443M 414M 607M | EV / Sales 2025 * | 0.32 x |
| P/E ratio 2024 * |
4.68
x | P/E ratio 2025 * |
4.03
x | Employees | 3,127 |
| Yield 2024 * |
8.89% | Yield 2025 * |
10.4% | Free-Float | 49.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +27.66% | ||
| 1 week | +69.81% | ||
| Current month | +12.50% | ||
| 1 month | +8.43% | ||
| 3 months | +36.36% | ||
| 6 months | +69.81% | ||
| Current year | +69.81% |
1 week
0.51
0.90
1 month
0.510.95
Current year
0.460.95
1 year
0.460.95
3 years
0.330.95
5 years
0.260.95
10 years
0.261.04
| Managers | Title | Age | Since |
|---|---|---|---|
Meng An
CEO | Chief Executive Officer | 52 | 21-03-23 |
Pei Cheng Fang
DFI | Director of Finance/CFO | 45 | 10-07-31 |
Han Xing Xu
BRD | Director/Board Member | 30 | 20-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Quan Zhu
BRD | Director/Board Member | 84 | 12-12-23 |
Zhong Shi Feng
BRD | Director/Board Member | 65 | 13-12-01 |
Yu Jun Chen
BRD | Director/Board Member | 44 | 13-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-28 | 0.9 | +27.66% | 146 |
| 24-06-27 | 0.705 | +3.68% | 3,000 |
| 24-06-26 | 0.68 | -12.26% | 3,500 |
| 24-06-25 | 0.775 | +13.97% | 500 |
| 24-06-24 | 0.68 | +30.77% | 500 |
Delayed Quote Deutsche Boerse AG, June 28, 2024 at 11:03 am
More quotes
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.175
CNY
Average target price
7.615
CNY
Spread / Average Target
+47.16%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +20.76% | 43.59B | |
| +28.00% | 22.54B | |
| +20.25% | 15.73B | |
| +18.82% | 14.33B | |
| +55.83% | 12.75B | |
| -0.05% | 6.79B | |
| -12.70% | 6.48B | |
| -8.87% | 5.73B | |
| +14.65% | 5.67B |
- Stock Market
- Equities
- 1681 Stock
- C1P Stock
